In terms of translational research, treatment of animal model glaucoma with D-amino acid oxidase (DAAO) has been shown to increase phosphorylation of ERK1/2 and increase the expression of p-MEK, an upstream regulator of ERK; these alterations are identified mainly in the ganglion cell layer and Müller cells [49]. Here, DAO is linked to glaucoma.